1-2 of 2 results for subject:Methylphenidate
Librarians' tools
- Search time
- 0.178 seconds
- Solr query time
- 0.001 seconds
- Search query
- subject:Methylphenidate
- We searched for
- subject_t:Methylphenidate OR subject_t:"Concerta XL" OR subject_t:"Methylphenidate hydrochloride" OR subject_t:Ritalin OR subject_ses:12526
Primary member
X
Calton, Patsy
Type
House
Session
Year
Department
Member
Primary member
More
Calton, Patsy (2)
Answering member
Legislative stage
Legislation
Subject
Publisher
To ask the Secretary of State for Health, what assessment he has made of the long-term effects of Ritalin.
To ask the Secretary of State for Health, what assessment he has made of the long-term effects of Ritalin.
Asked by
Patsy Calton
(Liberal Democrat)
Answered by
Stephen Ladyman
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
18 December 2003
For answer on
7 January 2004
Answered on
7 January 2004
Mrs. Calton: To ask the Secretary of State for Health what assessment he has made of the long-term effects of Ritalin. [145816]
Dr. Ladyman: Ritalin is indicated as a part of a comprehensive treatment programme for attention- deficit hyperactivity disorder
(ADHD) in children over six years of age where remedial measures alone prove insufficient. In October 2000 the National Institute
for Clinical Excellence (NICE) published an appraisal of the use of the drug methylphenidate (main brand name Ritalin) in the
treatment of childhood ADHD and issued clinical guidelines for its use, including the need for regular monitoring of children
receiving this therapy. NICE recommended long-term follow-up of adverse effects and the potential for misuse of the drug in
assessing long-term benefits and health gain into adulthood.
As with all medicines, the safety of methylphenidate is continually monitored by the Medicines and Healthcare products Regulatory
Agency and the independent advisory body the Committee on the Safety of Medicines. Comprehensive information on the use of
methylphenidate, including possible side effects, contraindications and precautions is contained in the summary of product
characteristics produced by the manufacturer and approved by the licensing authority.
Subjects
ADHD; Prescription drugs; Side effects; Methylphenidate
Date
7 January 2004
Reference
145816; 416 c397W
House
House of Commons
To ask the Secretary of State for Health, how many young people (a) under 11 and (b) over 11 have been prescribed Ritalin by a health authority in each of the last five years. - Inc table.
To ask the Secretary of State for Health, how many young people (a) under 11 and (b) over 11 have been prescribed Ritalin by a health authority in each of the last five years. - Inc table.
Asked by
Patsy Calton
(Liberal Democrat)
Answered by
Stephen Ladyman
(Labour)
Answering body
Department of Health
Type
Written questions
Status
Answered
Tabled on
18 December 2003
For answer on
7 January 2004
Answered on
7 January 2004
Mrs. Calton: To ask the Secretary of State for Health how many young people (a) under 11 and (b) over 11 have been prescribed
Ritalin by a health authority in each of the last five years. [145815]
Dr. Ladyman: Information is not available in the form requested. However the figures in the table following show the total number of
prescription items of methylphenidate hydrochloride dispensed in the community in England in each of the last five years. The
majority of prescription items of methylphenidate hydrochloride are for the brand Ritalin.
Number of prescription items of methylphenidate hydrochloride dispensed in the community in England--1998 to 2002
Thousand
_________________________________________________________________________________________________.
Total
1998 126.6
1999 158.0
2000 186.2
2001 208.5
2002 254.0
_________________________________________________________________________________________________.
Source: Prescription Cost Analysis data from the Prescription Pricing Authority
In 2002, around 91 per cent. of the 254,000 prescription items were dispensed in the community to children (children under 16 and
young people aged 16 to 18 in full time education). An estimated 1 per cent. of the items were dispensed to people aged 60 and over
with the remainder being dispensed to other adults. These proportions have been similar in recent years.
Subjects
Children; ADHD; Prescription drugs; Prescriptions; Methylphenidate
Date
7 January 2004
Reference
145815; 416 c397W
House
House of Commons